Immunotherapeutic aspects of stem cell transplantation

Hematology

Volumn 10, Issue SUPPL. 1, 2005, Pages 289-292

  Madrigal, J Alejandro ^a   Travers, Paul J ^a   Anthony Dodi, I ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; CD8 ANTIGEN; IMMUNOMODULATING AGENT; TETRAMER;

ADENOVIRUS; ADOPTIVE IMMUNOTHERAPY; ADOPTIVE TRANSFER; ASPERGILLOSIS; BK VIRUS; CYTOMEGALOVIRUS INFECTION; EPSTEIN BARR VIRUS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES VIRUS INFECTION; HERPES ZOSTER; HUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VIRUS INFECTION; VIRUS PNEUMONIA;

GRAFT VS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOTHERAPY; LEUKEMIA; OPPORTUNISTIC INFECTIONS;

EID: 29244478303     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245330512331390131     Document Type: Review

References (9)

1. Prasad VK, Heller G, Kernan NA, et al. The probability of HLA-C matching between patient and unrelated donor at the molecular level: estimations based on the linkage disequilibrium between DNA typed HLA-B and HLA-C alleles. Transplantation 1999;68:1044-1050.
2. Dorak TM, Poynton CH. In: Barrett J, Treleaven J, editors. The clinical practice of stem-cell transplantation. Oxford: Isis Medical Media; 1998. pp 326-351.
3. Dini G, Lamparelli T, Rondelli R, et al. Unrelated donor marrow transplantation for chronic myelogenous leukaemia. Br J Haematol 1998;102:544-552.
4. Marsh SGE, Parham P, Barber LD. The HLA Facts Book. London: Academic Press; 2000.
5. Hurley CK, Baxter-Lowe LA, Begovich AB, et al. The extent of HLA class II allele level disparity in unrelated bone marrow transplantation: analysis of 1259 National Marrow Donor Program donor-recipient pairs. Bone Marrow Transplant 2000;25:385-393.
6. Petersdorf EW, Gooley, Malkki M, et al. The biological significance of HLA-DP gene variation in haematopoietic cell transplantation. Br J Haematol 2001;112:988-994.
7. Clark RE, Dodi IA, Hill SC, Lill JR, Aubert G, Macintyre AR, Rojas J, Bourdon A, Bonner PLR, Wang L. Plenary paper: Direct evidence that leukaemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein. Blood 2001;98:2887-2893.
8. + bias in T cells cloned from a CML patient with active graft versus leukaemia effect. Cytotherapy, 2002;4:353-363.
9. Aubert G, Hassan-Walker AF, Madrigal JA, Emery VC, Morte C, Grace S, Koh MBC, Potter M, Prentice HG, Dodi IA, Travers PJ. Cytomegalovirus-specific cellular immune responses and viremia in recipients of allogeneic stem cell transplants. Journal of Infectious Diseases 2001;184:955-963.